Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain.
about
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterationsHepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethylnitrofurazone: a comparison with BenznidazoleEffects of astaxanthin in mice acutely infected with Trypanosoma cruziBlood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens.Drug strategies targeting CYP51 in neglected tropical diseasesVaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infectionExperimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development.Novel drug discovery for Chagas disease.Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs.In vitro and in vivo experimental models for drug screening and development for Chagas disease.Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging.Trypanosoma cruzi: clones isolated from the Colombian strain, reproduce the parental strain characteristics, with ubiquitous histotropism
P2860
Q24520510-98D7E70C-46C0-4C27-A740-0FE9C374F8E1Q28543851-804B7ADD-507E-40F2-A84B-5CAD0E13E42FQ30096798-D6431819-3AF7-4B12-9530-A3088024CABBQ34280628-589BEA77-02F7-430A-8EB5-9F41E833673DQ34622554-4B3ADA14-5567-407D-B85D-2176EC24A29CQ34700649-5986F44F-D62D-42A4-8487-ACC36B168E09Q35210866-2764502A-5B76-4123-9F5B-8F667E11DD75Q37124216-42C02F31-3945-4A42-8759-ECCA0B8943C6Q37732551-E1D764F5-EECF-4B8D-81C1-6D2BEED4F98AQ38770142-EFAD7C4B-F699-41D5-82D7-7C680BFE03D3Q39701339-B3B6DCF0-F891-42C8-B7FB-728E160B8A47Q43080976-FEF218AF-F531-4F2B-93AA-45DAE994D772Q46430988-633B386E-75F2-4E1B-B35D-7F39EC39F5B3Q52577966-67F44AB1-D066-4B4C-9561-63BCFF99095AQ58845281-F93F9579-80D5-4828-BFD5-EC54E22959E3
P2860
Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Trypanosoma cruzi: susceptibil ...... ly resistant Colombian strain.
@en
Trypanosoma cruzi: susceptibil ...... ly resistant Colombian strain.
@nl
type
label
Trypanosoma cruzi: susceptibil ...... ly resistant Colombian strain.
@en
Trypanosoma cruzi: susceptibil ...... ly resistant Colombian strain.
@nl
prefLabel
Trypanosoma cruzi: susceptibil ...... ly resistant Colombian strain.
@en
Trypanosoma cruzi: susceptibil ...... ly resistant Colombian strain.
@nl
P2093
P2860
P1476
Trypanosoma cruzi: susceptibil ...... ly resistant Colombian strain.
@en
P2093
Edson L P Camandaroba
Eliana A G Reis
Marilda S Gonçalves
Sonia G Andrade
P2860
P304
P356
10.1590/S0037-86822003000200002
P577
2003-03-01T00:00:00Z